Frontlight ResearchEarly access
Neuroendocrine tumours trials in Austria
1 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
- Where
- Graz, Linz, Vienna
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Ipsen
See details and how to joinNCT07314164